Attitudes toward medication and reasons for non-compliance in patients with schizophrenia

Indian Journal of Psychological Medicine

Volumn 36, Issue 3, 2014, Pages 294-298

  Chandra, Ivatury Sarath ^a   Kumar, Kalasapati Lokesh ^b   Reddy, Mallepalli Pramod ^a   Reddy, Chada Muni Pavan Kumar ^a  

^a Mamata Medical College and General Hospital   (India)

^b Bhaskara Medical College   (India)

Author keywords

Attitudes; non compliance; schizophrenia

Indexed keywords

EID: 84903939016     PISSN: 02537176     EISSN: 09751564     Source Type: Journal    
DOI: 10.4103/0253-7176.135383     Document Type: Article

References (26)

1. Rana NH, Ayub M. Non-compliance to medicine in psychiatry patients. Pak J Med Sci 2002;18:52-4
2. Rosack J. Education on medication adherence will reduce costs, improve outcome. Psychiatr News 2004;39:20
3. Terkelsen KG, Menikoff A. Measuring the costs of schizophrenia. Implications for the post-institutional era in the US. Pharmacoeconomics 1995;8:199-222
4. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909. (Pubitemid 35231730
5. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006;31:2033-46
6. Khanna BC. Treatment acceptance from walk-in clinic. Pilot study. (Unpublished data
7. Srinivasan TN, Thara R. At issue: Management of medication noncompliance in schizophrenia by families in India. Schizophr Bull 2002;28:531-5
8. Nageotte C, Sullivan G, Duan N, Camp PL. Medication compliance among the seriously mentally ill in a public mental health system. Soc Psychiatry Psychiatr Epidemiol 1997;32:49-56. (Pubitemid 27075690
9. WHO. International classification of diseases-10 research diagnostic criteria classification of mental and behavioural disorder, tenth revision, World Health Organization, Geneva; 1992
10. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76. (Pubitemid 18039085
11. Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull 1994;20:297-310. (Pubitemid 24171093
12. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychol Med 1983;13:177-83. (Pubitemid 13132147
13. Sparr LF, Moffitt MC, Ward MF. Missed psychiatric appointments: Who returns and who stays away. Am J Psychiatry 1993;150:801-5. (Pubitemid 23137689
14. Klinkenberg WD, Calsyn RJ. Predictors of receipt of aftercare and recidivism among persons with severe mental illness: A review. Psychiatr Serv 1996;47:487-96. (Pubitemid 26141367
15. Carpenter PJ, Morrow GR, Del Gaudio AC, Ritzler BA. Who keeps the first outpatient appointment?. Am J Psychiatry 1981;138:102-5. (Pubitemid 11209764
16. Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW. Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry 2004;65:354-60
17. Atwood N, Beck JC. Service and patient predictors of continuation in clinic-based treatment. Hosp Community Psychiatry 1985;36:865-9. (Pubitemid 15048011
18. Balikci A, Erdem M, Zincir S, Bolu A, Bozkurt A, Sarper E. Adherence with outpatient appointments and medication: A two-year prospective study of Patients with schizophrenia. Bull Clin Psychopharmacol 2013;23:57-64
19. Staring AB, Van Der Gaag M, Koopmans GT, Selten JP, Van Beveren JM, Hengeveld MW, et al. Treatment adherence therapy in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry 2010;197:448-55
20. McEvoy JP, Howe AC, Hogarty GE. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients. J Nerv Ment Dis 1984;172:412-6. (Pubitemid 14084520
21. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophr Bull 1997;23:637-51. (Pubitemid 27485972
22. Coodin S, Staley D, Cortens B, Desrochers R, McLandress S. Patient factors associated with missed appointments in persons with schizophrenia. Can J Psychiatry 2004;49:145-8. (Pubitemid 38387425
23. Adewuya AO, Ola BA, Mosaku SK, Fatoye FO, Eegunranti AB. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatr Scand 2006;113:207-11. (Pubitemid 43340873
24. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: Relationship to clinical variables and insight. J Clin Psychiatry 2004;65:1372-6
25. Rosa MA, Marcolin MA, Elkis H. Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia. Rev Bras Psiquiatr 2005;27:178-84. (Pubitemid 41337480
26. Loffler W, Killan R, Toumi M, Angermeyer MC. Schizophrenic patients subjective reasons for compliance and non compliance with neuroleptic treatment. Psychiatr Serv 2004;55:174-9